Director/PDMR Shareholding

RNS Number : 3225I
GlaxoSmithKline PLC
01 July 2013
 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

 

On 28 June 2013, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £16.39 per Ordinary Share, and notional ADSs at a price of $49.95 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2013 to 30 June 2013:

 

Non Executive Director

Ordinary Shares

American Depositary Shares (ADSs)




Sir Christopher Gent

2,593.045





Professor Sir Roy Anderson

552.929





Dr Stephanie Burns

                

462.187




Stacey Cartwright

438.530





Lynn  Elsenhans


831.937




Judy Lewent


391.854




Sir Deryck Maughan


1,083.369




Dr Daniel Podolsky


873.536




Tom de Swaan

514.796





Jing Ulrich


291.379




Hans Wijers

324.131





Sir Robert Wilson

477.501





 

The Company and the Non-Executive Directors were informed of these allocations on 1 July 2013.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

1 July 2013

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZFLFBXDFZBBE

Companies

GSK (GSK)
UK 100

Latest directors dealings